Arca Biopharma
And finally this week, Arca Biopharma has hired three new leaders in clinical development and quality assurance.
Dr Christopher Dufton (pictured), previously Director of Clinical Research at Gilead Sciences, has been named Vice President, Clinical Development. Sharon Perry, previously Director of Quality Assurance (QA) at Accera Pharma, will serve as Senior Director Quality. Jennifer Merriweather, previously Clinical Program Manager at Gilead Sciences, becomes the new Senior Clinical Program Manager.
Dr. Michael Bristow, CEO of Arca, said of the three new appointments:“Their understanding of the drug development process and clinical trial execution will be a tremendous asset as ARCA continues the development of Gencaro as a potential treatment for atrial fibrillation.”